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Abstract The unique case of two sisters with symptoms
of RTT and two quite distinct, novel, and apparently
de novo microdeletions of the MECP2 gene is described.
One sister possessed an 18 base-pair (bp) deletion
(c.1155_1172del18) within the deletion hotspot region of
exon 4, whereas the other sister exhibited a 43 bp deletion
at a different location in the same exon (c.1448_
1461del14?29). Although these lesions occurred on the
same paternally-derived X chromosome, this is probably
due to chance co-occurrence owing to the relatively high
mutation rate of the MECP2 gene rather than to a consti-
tutional mutator phenotype.
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Introduction
Rett syndrome (RTT; RTT MIM#312750) is an X-linked
dominant neurological disorder of development which
affects 1 in 10,000–15,000 females (Percy 2002; Chahrour
and Zoghbi 2007). Classic RTT has a characteristic pre-
sentation with subtle abnormalities in development from
birth, a period of stagnation, followed by regression
with loss of hand and social skills and development of
hand stereotypies, deceleration in head growth, severe
learning difficulties and gait dyspraxia (Weaving et al.
2005; Williamson and Christodoulou 2006).
Mutations in the MECP2 gene (MIM# 300005) were
first reported in RTT by Amir et al. (1999) and are identi-
fiable in *80% of classic RTT cases, although less
frequently in atypical RTT (Huppke and Ga¨rtner 2005).
The MECP2 gene contains four exons and encodes methyl-
CpG-binding protein-2 (MeCP2), a multifunctional protein
with at least four different functional domains: (i) a methyl-
CpG-binding domain, (ii) an arginine-glycine repeat
RNA-binding domain, (iii) a transcriptional repression
domain and (iv) an RNA splicing factor binding region
(WW group II binding domain) [Fan and Hutnick 2005].
Two distinct isoforms have been reported; MECP2A is
encoded by exons 2–4 whereas MECP2B is encoded by
exons 1, 3 and 4 (Mnatzakanian et al. 2004). To date, more
than 200 different nucleotide substitutions have been
reported in the MECP2 gene as a cause of RTT (RettBASE,
http://mecp2.chw.edu.au; Miltenberger-Miltenyi and Lac-
cone 2003; Williamson and Christodoulou 2006). In
addition, *10% of RTT patients possess microdeletions
which cluster within a *150 bp exon 4 hotspot region,
between nucleotides 1050 and 1200 (Williamson and
Christodoulou 2006; Bienvenu and Chelly 2006; Philippe
et al. 2006).
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The vast majority of RTT cases are sporadic ([99%),
but some familial cases have been described which are
usually caused by either maternal or paternal germline
mosaicism (Evans et al. 2006; Venaˆncio et al. 2007) or
skewing of X-inactivation towards the wild-type MECP2
allele in the asymptomatic carrier mother (Villard et al.
2001; Knudsen et al. 2006; Dayer et al. 2007). In such
cases, affected relatives invariably possess the same
molecular lesion. Here, we describe the unique case of two
sisters with symptoms of RTT who were found to have two
quite distinct, and apparently de novo, microdeletions on
the same paternally-derived MECP2 allele.
Case report
Two sisters with Rett syndrome were born to healthy non-
consanguineous Irish parents (Fig. 1). Case 1, now aged
11, was born after an uncomplicated pregnancy, weighing
3.6 kg. The maternal age was 36 years, and the paternal
age 40 years. Feeding was initially poor, although this
improved on bottle feeds, and she gained weight rapidly.
She was described as a very placid baby, and from the age
of 7 months, concerns were raised about significant mus-
cular hypotonia, regressing attentiveness and slowing of
head growth. At around the same time, she started to
develop seizures upon waking, as well as ritualistic table-
banging. She did not achieve a stable sitting posture, and
never developed recognisable speech. Classical ‘hand-
wringing’ stereotypies were not, however, observed. Head
growth stalled at 47.3 cm at the age of 3 years 7 months
(0.4 cm below the 0.4th centile). Other growth parameters
were within the normal range. MRI brain scan was reported
as normal, but electroencephalograms (EEGs) showed
frequent central and Sylvian epileptiform discharges. The
karyotype was normal as was testing for Prader-Willi and
Angelman syndromes.
Case 2, now 4 years of age, weighed 3.24 kg at term.
The pregnancy was largely uncomplicated, although
occasional periods of fetal inactivity were noted by the
mother (now aged 47 years; father 51 years). She was
noted to be quite floppy during feeding but was able to sit
at 9 months, and walked unsteadily from 18 months.
Developmental progression was slow, with no recognisable
speech, although she did babble. She did not develop
imaginative play, and engaged in frequent hand-wringing
and clapping. On assessment at age 2 years 4 months, she
was markedly hypotonic but non-dysmorphic. Height and
weight were on the 25th and 75th centiles, respectively, but
head circumference was on the 9th centile, and had stalled
at 48 cm by 3 years 4 months (*2nd centile). Further
developmental regression had been noted from the age of
2 years 6 months, with loss of stacking skills and spoon
handling ability. She did not have seizures. MRI brain scan
was normal but an EEG has not yet been carried out. The
affected girls have two apparently normal sisters.
Materials and methods
DNA sequencing
Polymerase chain reaction (PCR) amplification of the four
exons of the MECP2 gene was performed using oligonu-
cleotide primers and amplification conditions described by
Cheadle et al. (2000). PCR products and plasmid clones
were sequenced using Thermosequenase (Amersham
Pharmacia, Little Chalfont, UK) according to the manu-
facturers’ instructions. PCR-amplified genomic fragments
were then sequenced in both directions using the primers
used for PCR amplification.
Cloning of PCR amplified fragments
Exon 4 of the MECP2 gene was PCR amplified from DNA
derived from both sisters and their parents as described
above. PCR fragments were cloned into pGEM-T (Promega,
Southampton, UK). Four clones from each individual were
then sequenced in both directions using vector-based prim-
ers pGEMT5B (50 CAGTCACGACGTTGTAAAACG 30)
and pGEMT3B (50 ATGACCATGATTACGCCAAGC 30)
using BigDye v3.1 (Applied Biosystems, Warrington, UK)
and analysed on an ABI 3100 sequencer (Applied Biosys-
tems, Warrington, UK).
Results
Sequencing of the MECP2 gene in Case 1 revealed a novel
18 base-pair (bp) deletion, c.1155_1172del18, within the
deletion hotspot region in exon 4 (Fig. 2). Although this







Fig. 1 Pedigree of the affected family; The clinically affected sisters
(Cases 1 and 2) are denoted by filled circles. The MECP2 genotypes
of the sisters are given. The paternal inheritance of the c.1373G[A
transition is indicated
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in-frame and would be predicted to lead to the loss of amino
acid residues 386–391. When sequencing was performed on
the younger sister (Case 2), a quite different 43 bp deletion
was detected which spans the junction between exon 4
and the 30 UTR viz. c.1448_1461del14?29 (Fig. 2). This
frameshift deletion would be predicted to lead to the syn-
thesis of an elongated protein product (in which the last four
amino acids of MeCP2 would be replaced by a novel stretch
of 14 amino acids at the C-terminal end of the protein).
However, in the absence of protein studies, it remains
unclear if a stable protein product would actually be pro-
duced. Neither microdeletion was found by PCR/direct
sequencing analysis to be present in the constitutional
(lymphocyte) DNA of the parents, indicating that these
lesions probably occurred de novo. According to the
MECP2 Variation Database (RettBASE; http://mecp2.chw.
edu.au/), neither microdeletion has been previously repor-
ted, either as a pathological lesion or as a polymorphic
variant.
Both sisters also carried a novel missense variant in exon
4 of the MECP2 gene, c.1373G[A (p.Arg458His; Figs. 2,
3). No examples of this nucleotide substitution have previ-
ously been reported (RettBASE; http://mecp2.chw.edu.au/).
This G[A transition is located within a potentially hyper-
mutable CpG dinucleotide and is compatible with a
mutational mechanism of methylation-mediated deamina-
tion of 5-methylcytosine. Arg458 is conserved in both
mouse and Xenopus laevis MeCP2 (Amir et al. 1999) and
such evolutionary conservation often implies biological
function. However, the Arg458His substitution is also
present in the constitutional DNA of the clinically normal
father indicating that, irrespective of its possible functional
relevance, it is most unlikely to be of pathological signifi-
cance. This notwithstanding, the presence of this rare
paternal c.1373G[A variant in both affected sisters renders
the twin possibilities of sample mix-up and non-paternity in
a diagnostic context highly unlikely.
The rare c.1373G[A variant serendipitously provided a
marker for the paternal MECP2 allele in this family. The
sequencing of cloned exon 4-containing fragments in the























Fig. 2 Sequence of exon 4 of the MECP2 gene showing the locations









































Fig. 3 Repetitive sequence elements in the vicinity of the microde-
letion breakpoints and the secondary structures postulated to have
been involved in the genesis of the two mutations. Lower case letters
denote deleted nucleotides. (a) Repetitive sequence elements (shown
in bold) found in the vicinity of the breakpoints of the
1155_1172del18 microdeletion. (b) Repetitive sequence elements
(shown in bold) found in the vicinity of the breakpoints of the
1448_1461del14?29 microdeletion. (c) Schematic representation of
the postulated non-B DNA slipped structures at the breakpoint of the
1448_1461del14?29 microdeletion. The nucleotides shown in bold
type correspond to the direct repeats shown in (b). Nucleotides circled
in grey denote the homology between two breakpoint junctions. The
arrows indicate the sequences deleted
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had occurred in cis to the paternal c.1373G[A variant. We
may therefore conclude that both microdeletions occurred
independently on the same paternal allele. This is consis-
tent with the observations of Trappe et al. (2001) that most
de novo MECP2 gene lesions in RTT arise on the pater-
nally derived X chromosome.
Complexity analysis (Gusev et al. 1999) was used to
examine the potential role of the local DNA sequence
environment in mediating the two microdeletions in the
MECP2 gene. Several repetitive sequence elements were
identified which could have mediated the two mutational
events. Deletion 1155_1172del18, which occurred within
the deletion hotspot region, could have been mediated by
two CCACC direct repeats via slipped mispairing (Fig. 2a).
However, the 1448_1461del14?29 deletion appears to be
more complex and may have originated via either one of
two distinct deletions both of which could have been
mediated by direct repeats. These repeats, GAG and CAA
(Fig. 2b), appear to be capable of forming slipped struc-
tures (Fig. 2c). Such slipped structures can adopt non-B
DNA conformations which are known to be susceptible to
double strand breaks and hence are also highly mutagenic
(Wang and Vasquez 2006).
Discussion
The vast majority of cases of Rett syndrome (RTT) are
female and sporadic. However, a number of familial cases
of RTT, exhibiting recurrent RTT within a sibship, have
been reported and have generally been explained either by
parental gonadal mosaicism or by a clinically unaffected
carrier mother with skewed X-inactivation; in such cases,
affected relatives have invariably possessed the same
molecular lesion (Villard et al. 2000; Mari et al. 2005;
Archer et al. 2007; Hardwick et al. 2007; Venaˆncio et al.
2007). As far as we are aware, the independent occurrence
of two non-identical MECP2 gene lesions in the same
family, as reported here, is unprecedented. The question
therefore arises as to whether the X chromosome upon
which the microdeletions arose could somehow be pre-
disposed to mutation. Although both microdeletions
occurred on the same paternally inherited chromosome
and within the WW group II binding domain, only
c.1155_1172del18 occurred within the deletion hotspot
region in exon 4. Moreover, the two micro-deletions appear
to have arisen via entirely different mutational mecha-
nisms. Finally, inspection of the sequence of the affected
MECP2 allele failed to identify any private sequence
characteristics that could account for a particular predis-
position to deletional mutagenesis on this paternally-
derived chromosome. We therefore conclude that, in all
likelihood, this unique occurrence of two non-identical
MECP2 gene lesions within a sibship probably represents a
chance event.
This case is reminiscent of our previous report of a
family with three individuals displaying clinical evidence
of neurofibromatosis type 1 (NF1) who were found to
possess three different heritable and pathological mutations
in their NF1 genes (Upadhyaya et al. 2003). Although
several possible explanations for this unique finding were
considered, including the possibility that the NF1 alleles
segregating in the family might be unstable, on balance we
concluded that it probably represented chance co-occur-
rence (Upadhyaya et al. 2003). These cases are not
altogether without precedent. Indeed, other such examples
of independently segregating non-identical pathological
gene lesions have involved the NF1 gene in a second quite
unrelated family with NF1 (Klose et al. 1999), the RB1
gene in a family with retinoblastoma (Munier et al. 1993)
and the APC gene in a family with adenomatous polyposis
coli (Davidson et al. 2002). Examples of this phenomenon
have also been reported in the X-linked recessive condi-
tions haemophilia A (Tizzano et al. 2005) and Duchenne/
Becker muscular dystrophy (Laing et al. 1992; Mostacci-
uolo et al. 1994; Morandi et al. 1995; Zatz et al. 1998).
Irrespective of whether these cases represent examples of
mutationally unstable alleles or simply chance co-occur-
rence owing to the relatively high mutation rates exhibited
by some of these genes, such reports should serve as a stark
reminder that it is unwise to extrapolate from the detection
of a single mutation in a specific individual to the
assumption of an identical molecular genetic aetiology in
other clinically affected members of the same family.
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